"Multimodal diagnosis and therapy in oncology—in an era of molecular medicine, increased patient expectations and cost reduction—require real-time multidisciplinary management.2Unfortunately, medicine has not universally adopted real-time, team-based patient care management. Instead, medicine continues to use the outdated tumour board, which typically meets weekly and gathers numerous subspecialists at a specified time and location to discuss some or all of the oncology cases identified in the preceding days or weeks. The slow process of identifying cases for presentation, gathering information and confirming attendance of the participants who have knowledge of particular cases is usually the responsibility of a cancer committee coordinator or tumour registrar. Accordingly, key patient care decisions are often delayed at high cost and with dubious clinical treatment value."
No comments:
Post a Comment